Institut für Humangenetik
Refine
Has Fulltext
- yes (139)
Is part of the Bibliography
- yes (139)
Year of publication
Document Type
- Journal article (126)
- Doctoral Thesis (13)
Language
- English (139) (remove)
Keywords
- DNA methylation (9)
- BRCA1 (5)
- DNA repair (5)
- breast cancer (5)
- heterochromatin (5)
- mutations (5)
- ovarian cancer (5)
- Anura (4)
- Fanconi anemia (4)
- Fanconi-Anämie (4)
- consortium (4)
- epigenetics (4)
- gene (4)
- genetics (4)
- 5-Methylcytosine (3)
- DNS-Reparatur (3)
- Epigenetik (3)
- Genmutation (3)
- Medizin (3)
- Methylierung (3)
- cancer (3)
- genetic modifiers (3)
- genome-wide association (3)
- immunofluorescence (3)
- investigators (3)
- methylation (3)
- sperm (3)
- susceptibility loci (3)
- zebrafish (3)
- 2B (2)
- ADHD (2)
- B chromosomes (2)
- BRCA2 (2)
- Candida albicans (2)
- DNA (2)
- Epigenetics (2)
- FISH (2)
- FSHD (2)
- Fabry disease (2)
- Fabry genotype (2)
- Fabry phenotype (2)
- Fanconi Anämie (2)
- HPP (2)
- Makuladegeneration (2)
- Netzhaut (2)
- RPE (2)
- SLX4 (2)
- STR profile (2)
- Spermium (2)
- TNAP (2)
- VMD2 (2)
- bisulfite pyrosequencing (2)
- blood (2)
- common variants (2)
- copy number variation (2)
- diagnosis (2)
- disease genetics (2)
- duchenne muscular dystrophy (2)
- exome sequencing (2)
- extracellular matrix (2)
- fetal programming (2)
- fibrosis (2)
- genetic diagnostics (2)
- genome (2)
- genomic imprinting (2)
- gestational diabetes mellitus (2)
- gridle muscular-dystrophy (2)
- hearing impairment (2)
- hearing loss (2)
- hepatic stellate cell (2)
- hereditary breast and ovarian cancer (2)
- hypophosphatasia (2)
- immunodeficiency (2)
- intellectual disability (2)
- liver (2)
- microcephaly (2)
- mineralization (2)
- modifiers (2)
- mutation (2)
- myofibrillar myopathy (2)
- myofibroblast (2)
- myopathy (2)
- nervous system (2)
- next generation sequencing (2)
- next generation sequencing (NGS) (2)
- protein (2)
- sensory neuropathy (2)
- sex chromosomes (2)
- single-nucleotide polymorphisms (2)
- skeletal dysplasia (2)
- somatic mosaicism (2)
- spectral karyotyping (2)
- sperm DNA methylation (2)
- survival (2)
- variants (2)
- whole exome sequencing (2)
- whole-exome sequencing (2)
- (classical and atypical) Werner syndrome (1)
- 3D modeling (1)
- 3R (1)
- 5-methylcytosine (1)
- A chromosomes (1)
- AFLP (1)
- AKT-signaling (1)
- ALPL (1)
- AMD (1)
- ART outcome (1)
- ATM gene (1)
- Age-related macular degeneration (1)
- Allophrynidae (1)
- Alzheimer's disease (1)
- Alzheimerkrankheit (1)
- Anticoagulants (1)
- Asisted Reproduction (1)
- Aspergillus fumigatus (1)
- Autism (1)
- Autism spectrum disorders (1)
- Autismus (1)
- B4GALT7 gene (1)
- BMD (1)
- BRCA1/2 (1)
- BRIP1 gene (1)
- Best Disease (1)
- Best-Krankheit (1)
- Bioinformatics (1)
- Blasentumor (1)
- BrdU replication banding pattern (1)
- BrdU/dT replication banding (1)
- Brustkrebs (1)
- CAGSSS (1)
- CDC14A (1)
- CIN (1)
- CLRN2 (1)
- COVID-19 (1)
- CRISPR-Cas Systems (1)
- CRISPR/Cas9 (1)
- Centrolenidae (1)
- Charcot-Marie-Tooth neuropathy 1A (1)
- Checkpoints (1)
- Chromosomal instability (1)
- Chromosomenbruch (1)
- Coagulation factor IX (1)
- Coexpression (1)
- Cognitive control (1)
- Copy number variation (1)
- Cortex (1)
- Coumarin (1)
- Cranial sutures (1)
- D4Z4 partial deletion (1)
- DFNB32 (1)
- DFNB68 (1)
- DLX5/6 (1)
- DM2 (1)
- DNA Methylation (1)
- DNA Reparatur (1)
- DNA damage (1)
- DNA double-strand break (1)
- DNA methylation (DNAm) age (1)
- DNA methylation dynamics (1)
- DNA methyltransferase gene (1)
- DNA repair defect (1)
- DNA sequencing (1)
- DNA-Instabilitätssyndrom (1)
- DNA-Methylation (1)
- DNA-Quervernetzung (1)
- DNA-Repair (1)
- DNA-repair (1)
- DNA-repair genes (1)
- DNMT3B (1)
- DYNC1I1 (1)
- Damage (1)
- Deflazacort (1)
- Down syndrome (1)
- Duchenne dystrphy (1)
- Duchenne muscular dystrophy (1)
- ERCC1-XPF (1)
- ERCC4 (1)
- Embryos (1)
- Enhancer elements (1)
- Environment (1)
- Epigenotypus (1)
- Epimutation (1)
- Erbkrankheit (1)
- Evans syndrome (1)
- Extracellular matrix (1)
- FA (1)
- FANCA (1)
- FANCD2 (1)
- FANCP (1)
- Familial Beckwith-Wiedemann syndrome (1)
- Fanconi Anemia (1)
- Fanconi anaemia (1)
- Fanconi-anemia subtype (1)
- Fetal brain development (1)
- Fluorescence in situ hybridization (1)
- Fourthcorner analysis (1)
- Frontal cortex (1)
- GTL2 (1)
- Gecko (1)
- Gen (1)
- Gene-expression (1)
- Genes (1)
- Genetik (1)
- Genome (1)
- Genotype-phenotype association (1)
- Genotype–phenotype correlations (1)
- Hereditary breast cancer (1)
- High-throughput data (1)
- Hindbrain (1)
- Histologic grade (1)
- Holliday junction reolvass (1)
- Human prefrontal cortex (1)
- Hypophosphatasia (1)
- IARS2 (1)
- ICF2 (1)
- ICL (1)
- ICSI (1)
- IGF2-H19 (1)
- II citrullinemia (1)
- IMSI (1)
- Imprinting (1)
- Indian muntjac (1)
- Induced Pluripotent Stem Cells (1)
- Instability (1)
- KRAS (1)
- Keimzell- und Embryonalentwicklung (1)
- LGMDR5 (1)
- Limb development (1)
- Limb girdle muscular dystrophy (LGMD) (1)
- Long-term follow-up (1)
- MCPH1 (1)
- MEK/ERK-signaling (1)
- MFM (1)
- Male breast cancer (1)
- Malignant neoplasms (1)
- Mausmodell (1)
- Membranproteine (1)
- Methylome (1)
- Microarray analysis (1)
- Miyoshi myopathy (1)
- Molecular approaches (1)
- Molekularbiologie (1)
- Molekulargenetik (1)
- Morbus Best (1)
- Mosaizismus (1)
- Mucopolysaccharidosis IIIa (1)
- Multivariate analysis (1)
- Mutation (1)
- Mutationen (1)
- Mutationsanalyse (1)
- N170 (1)
- NEIL2 (1)
- Neanderthal (1)
- Neisseria meningitidis (1)
- Neuroepigenomics (1)
- Neurons (1)
- Next generation sequencing (1)
- OGG1 (1)
- Ordination methods (1)
- Ovarian (1)
- P100 (1)
- PCR (1)
- Pakistan (1)
- Parent-of-origin (1)
- Paternal age effect (1)
- Pathology (1)
- Patterns (1)
- Pigmentepithel (1)
- Pompe disease (1)
- RAD50-Defizienz (1)
- RAD51C (1)
- RAD52 (1)
- RLQ analysis (1)
- RNA metabolism (1)
- RNA-Seq analysis (1)
- RPE specific genes (1)
- Renal abnormalities (1)
- Repair (1)
- Reproduktionsmedizin (1)
- Retina (1)
- Reversion (1)
- Robertsonian translocation chromosomes (1)
- S1PR2 (1)
- SARS-CoV-2 (1)
- SH3 domain (1)
- SHFM (1)
- SKY analysis (1)
- SLC2A3 (1)
- SNP array (1)
- SNP-microarray (1)
- Schizophrenia (1)
- Selective attention (1)
- Self-renewal (1)
- Senile Makuladegeneration (1)
- Senile Makuladegeneration / Pigmentepithel / Genexpression (1)
- Skull (1)
- Somites (1)
- Spermien (1)
- Stability (1)
- Staphylococcus aureus (1)
- Suicidal behavior (1)
- Susceptibility (1)
- TMEM43 (1)
- TRIM32 (1)
- TYPE-2 (1)
- Terminal 4q deletion syndrome (1)
- Th17 (1)
- Transcription (1)
- Transcription regulation (1)
- Transcriptome (1)
- Transcriptomics (1)
- Transkription <Genetik> (1)
- Transkriptome (1)
- Tregs (1)
- UBZ (1)
- Urodela (1)
- Usher syndrome (1)
- VKORC1 (1)
- Vater (1)
- Visualization (1)
- Vitamin K epoxide reductase (1)
- Väterliches Alter (1)
- WDR62 mutation (1)
- Warfarin (1)
- Working memory (1)
- X chromosome (1)
- X-chromosomal inactivation (1)
- X. laevis-type karyotype (1)
- X. tropicalis-type karyotype (1)
- Xenopus (1)
- Xenopus laevis (1)
- Xenopus tropicalis (1)
- Y chromosome degeneration (1)
- ZBTB24 (1)
- ZBTB24 mutations (1)
- ZNF365 (1)
- ZW sex chromosomes (1)
- Zebrafish (1)
- Zellzyklus (1)
- abnormalities (1)
- adenoma (1)
- adrenal insufficiency (1)
- age at onset (1)
- age-related differentially methylated regions (ageDMRs) (1)
- aldehydes (1)
- alleles (1)
- allopolyploidy (1)
- alternative methods (1)
- alu elements (1)
- alzheimers disease (1)
- amphiphysin-2 BIN1 (1)
- amplicon sequencing (1)
- antidepressants (1)
- anxiety disorders (1)
- apoptosis (1)
- arrhythmogenic cardiomyopathy (1)
- asexual reproduction (1)
- assistierte Reproduktion (1)
- association (1)
- autism (1)
- autophagy (1)
- autopolyploidy (1)
- autosomal recessive hearing loss (1)
- autosomal recessive non-synstromic hearing loss (1)
- banding analyses (1)
- bcl-2 associated athanogene protein 3 (1)
- behavior (1)
- bestrophin (1)
- bioinformatics and computational biology (1)
- bleding disorders other than hemophilia (1)
- bone development (1)
- bone marrow failure syndrome (1)
- bovine (1)
- breast cancer predisposition (1)
- breast cancer predisposition genes (1)
- breast neoplasms (1)
- cadherins (1)
- cancer treatment (1)
- candida genome database (1)
- candidate genes (1)
- cardiogenetics (1)
- cardiomyopathy (1)
- case report (1)
- cataracts (1)
- cell (1)
- cell death (1)
- cell division (1)
- cell wall (1)
- centromeric instability (1)
- childhood cancer (1)
- children (1)
- chip-seq (1)
- chromosomal abnormality (1)
- chromosomal instability (1)
- chromosomale Instabilität (1)
- chromosome evolution (1)
- chromosome inversion (1)
- chromosome staining (1)
- chromsomal instability (1)
- classification (1)
- combined retinal dystrophy (1)
- comparative genomics (1)
- complex chromosome rearrangements (1)
- complex disorders (1)
- complex traits (1)
- computational prediction (1)
- congenital heart-deffects (1)
- congenital myopathy (1)
- connective tissue disorder (1)
- consanguinity (1)
- copy number variation (CNV) (1)
- copy-number variation (1)
- craniosynostosis (1)
- cross-link repair (1)
- cytokinesis (1)
- cytotoxicity (1)
- damage (1)
- danazol (1)
- danio rerio (1)
- database (1)
- deafness (1)
- deep bisulfite sequencing (1)
- deficiency (1)
- delayed radiation effects (1)
- deletion (1)
- design (1)
- developmental origins hypothesis (1)
- diagnostic delay (1)
- differentially methylated region (1)
- differentiation (1)
- diploidization (1)
- disease (1)
- disruption project (1)
- double trouble (1)
- double-strand DNA breaks (1)
- duplication (1)
- duplication-deficiency (1)
- dysferlinopathy (1)
- dystrophin (1)
- eExons (1)
- early respiratory-failure (1)
- elective surgery (1)
- elements (1)
- embryos (1)
- endonuclease (1)
- epigenetic heterogeneity (1)
- epimutation (1)
- epithelial cells (1)
- establishment (1)
- euchromatin (1)
- evolutionary biology (1)
- evolutionary fixation (1)
- expansion (1)
- expression signature (1)
- extreme phenotypes (1)
- facial anomalies (1)
- facioscapulohumeral muscular dystrophy (1)
- familial breast cancer (1)
- families (1)
- fanconi anemia (1)
- fanconi-anemia (1)
- features (1)
- female (1)
- female Fabry patients (1)
- fetal brain development (1)
- fetal cord blood (1)
- fetal overnutrition (1)
- fibroblasts (1)
- filamin C (1)
- fine-scale mapping (1)
- fish (1)
- flies (1)
- frameshift (1)
- frontal cortex (1)
- functional analysis (1)
- functional modules (1)
- geckos (1)
- gene mutations (1)
- genetic causes of cancer (1)
- genetic counselling (1)
- genetic diagnosis (1)
- genetic heterogeneity (1)
- genetic interaction networks (1)
- genetic loci (1)
- genetic skeletal disorders (1)
- genetic susceptibility (1)
- genetic testing (1)
- genetic variants (1)
- genome sequencing (1)
- genome-wide association study (GWAS) (1)
- genome-wide linkage analysis (1)
- genomic analysis (1)
- genomic instability (1)
- genomic libraries (1)
- genomics (1)
- genotype-phenotype correlation (1)
- genotyping arrays (1)
- germline mutations (1)
- global DNA methylation (1)
- glycogenin 1 (1)
- gonads (1)
- granulomas (1)
- great dane (1)
- growth (1)
- growth failure (1)
- growth hormone deficiency (1)
- gynogenesis (1)
- hand/foot malformation (1)
- haplogroups (1)
- haploinsufficiency (1)
- helicase BRIP1 (1)
- hematology (1)
- hemostasis and thrombosis (1)
- hereditary breast cancer (1)
- hereditary hearing loss (1)
- hereditary motor (1)
- hereditary motor and sensory neuropathy (1)
- heterogeneity (1)
- heteromorphic sex chromosomes (1)
- heterozygote (1)
- histological subtype (1)
- homoeologous chromosomes (1)
- hormone-related protein (1)
- host cells (1)
- human disease (1)
- human evolution (1)
- human medicine (1)
- humans (1)
- hybridogenesis (1)
- hypermethylated DNA (1)
- hypermethylation (1)
- illumina (1)
- immune thrombocytopenia (1)
- imprinting control region (1)
- in situ hybridization (1)
- in vitro model (1)
- incidence (1)
- induced pluripotent stem cells (1)
- infinium HumanOmni1-Quad (1)
- inflammation (1)
- inflammatory diseases (1)
- inherited myopathy (1)
- insulin treatment (1)
- intergenerational contraction (1)
- interolog (1)
- interstrand crosslink (1)
- intrachromosomal telomeric sequences (1)
- inversion (1)
- italian patients (1)
- karyotype evolution (1)
- kinase signaling (1)
- limb development (1)
- linked myotubular myopathy (1)
- live-born (1)
- loss of chromosome Y (LOY); (1)
- lymphoma (1)
- lyso‐Gb3 (1)
- macrophages (1)
- macular degeneration (1)
- maintenance (1)
- male breast cancer (1)
- malformations (1)
- mammalian male germline (1)
- mammographic density (1)
- medical genetics (1)
- meiosis (1)
- meiotic chromosomes (1)
- meiotic ‘superring’ (1)
- membrane curvature (1)
- membrane repair (1)
- mental retardation (1)
- metabolic disease (1)
- metabolism (1)
- methylation array (1)
- methylation array analysis (1)
- mice (1)
- microdeletion syndrome (1)
- microdissection (1)
- midbody (1)
- middle aged (1)
- mineraliztion (1)
- missense mutations (1)
- mitotic chromosomes (1)
- mixed hearing loss (1)
- mixed mutation mechanisms (1)
- miyoshi myopathy (1)
- model (1)
- moderate-penetrance genes (1)
- molecular analysis (1)
- molecular cloning (1)
- monoubiquitination (1)
- monozygotic twins (1)
- mosaicism (1)
- mouse (1)
- mouse model (1)
- multiple diseases (1)
- multiple myeloma (1)
- muscle disease (1)
- muscle strength (1)
- muscular dystrophy (1)
- muscular-dystrophy (1)
- mutation analysis (1)
- natural variation (1)
- network analysis (1)
- network inference (1)
- networks (1)
- neurodevelopmental disorders / genetics (1)
- neuromuscular disease (1)
- neurotransmission (1)
- neutrophils (1)
- next-generation sequencing (1)
- next-generation-sequencing (1)
- nomenclature (1)
- non-mosaic (1)
- non-sense mediated mRNA decay (1)
- nonspecific alkaline-phosphae (1)
- oocytes (1)
- organ toxicity (1)
- overlapping syndrome (1)
- oxidative stress (1)
- p.R245H (1)
- p.S298P (1)
- painful (1)
- panel sequencing (1)
- panic disorder (1)
- paternal age (1)
- paternal age effect (1)
- paternal introgression (1)
- pathogen-host interaction (PHI) (1)
- pathogenicity (1)
- pathway (1)
- patient (1)
- penetrance (1)
- phalloidin stain (1)
- phenotype (1)
- phenotypic spectrum (1)
- phosphoproteome (1)
- platelet disorders (1)
- polymerase chain reaction (1)
- polymorphism (1)
- polyneuropathy (1)
- polyploidization (1)
- polyploidy (1)
- population (1)
- potential role (1)
- prednisone (1)
- premature aging (1)
- premutation (1)
- prevalence (1)
- promoter methylation (1)
- promotes (1)
- protein aggregation (1)
- protein interaction database (1)
- protein-protein interaction (1)
- proteins (1)
- proteomic signature (1)
- protocadherin gamma cluster (1)
- radiation-induced genome instability (RIGI) (1)
- recessive inheritance (1)
- reciprocal translocation (1)
- recombination (1)
- recurrence (1)
- regulatory T cells (1)
- regulatory mutations (1)
- reproduction (1)
- requency (1)
- reversion (1)
- rhodamine–phalloidin stain (1)
- risk (1)
- sarcoglycanopathy (1)
- sarcotubular myopathy (1)
- screening (1)
- secondary cancer (1)
- segmental progeria (1)
- selection (1)
- sensorineural hearing loss (1)
- sequence alignment (1)
- sequence assembly tools (1)
- sex chromosome evolution (1)
- sex linked pigmentation pattern (1)
- sex ratio (1)
- sexual antagonistic genes (1)
- short stature (1)
- skeletal muscle (1)
- skeletal myopathy (1)
- sky kinases (1)
- species-specific epigenetic marks (1)
- spinal muscular atrophy (1)
- splicing (1)
- spondylodysplastic Ehlers-Danlos syndrome (1)
- steroids (1)
- stress fibers (1)
- structural genome variations (1)
- submicroscopic chromosome rearrangement (1)
- subtypes (1)
- suppression (1)
- susceptibility (1)
- susceptibility alleles (1)
- susceptibility gene (1)
- synaptonemal complex (1)
- systemic sclerosis (1)
- targeted gene panel (1)
- teeth (1)
- telomere length (1)
- telomeres (1)
- temperature (1)
- testes (1)
- testosterone (1)
- therapy (1)
- throat (1)
- tinnitus (1)
- tissue-specific enhancers (1)
- transcription deficiency (1)
- transcriptional regulation (1)
- transcriptome (1)
- transgenic animals (1)
- transporter gene SLC2A3 (1)
- transposable elements (1)
- treatment guidelines (1)
- triple-negative breast cancer (1)
- triplosufficiency (1)
- trisomy 21 (1)
- trisomy 22 (1)
- tumor subtypes (1)
- tumor-suppressor (1)
- twin study (1)
- type II esophageal achalasia (1)
- ubiquitin (1)
- vacuolar myopathy (1)
- ventilation (1)
- vertebrate (1)
- whole genome sequencing (1)
- whole genome sequencing (WGS) (1)
- α‐GalA 3D‐structure (1)
Institute
- Institut für Humangenetik (139)
- Theodor-Boveri-Institut für Biowissenschaften (28)
- Kinderklinik und Poliklinik (6)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (5)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (5)
- Medizinische Klinik und Poliklinik I (5)
- Neurologische Klinik und Poliklinik (4)
- Lehrstuhl für Orthopädie (3)
- Institut für Anatomie und Zellbiologie (2)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
Sonstige beteiligte Institutionen
- Comprehensive Hearing Center, Department of ORL, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, Würzburg, Germany (1)
- DNA Analytics Core Facility, Biocenter, University of Würzburg, Würzburg, Germany (1)
- Department of Animal Ecology and Tropical Biology, University of Würzburg, Würzburg, Germany (1)
- Maastricht University, Maastricht, the Netherlands (1)
Background: Autosomal recessive primary microcephaly (MCPH) is a rare neurodevelopmental disease with severe microcephaly at birth due to a pronounced reduction in brain volume and intellectual disability. Biallelic mutations in the WD repeat-containing protein 62 gene WDR62 are the genetic cause of MCPH2. However, the exact underlying pathomechanism of MCPH2 remains to be clarified.
Methods/results: We characterized the clinical, radiological, and cellular features that add to the human MCPH2 phenotype. Exome sequencing followed by Sanger sequencing in a German family with two affected daughters with primary microcephaly revealed in the index patient the compound heterozygous mutations c. 1313G>A (p.R438H) / c.2864-2867delACAG (p.D955Afs*112) of WDR62, the second of which is novel. Radiological examination displayed small frontal lobes, corpus callosum hypoplasia, simplified hippocampal gyration, and cerebellar hypoplasia. We investigated the cellular phenotype in patient-derived lymphoblastoid cells and compared it with that of healthy female controls. WDR62 expression in the patient's immortalized lymphocytes was deranged, and mitotic spindle defects as well as abnormal centrosomal protein localization were apparent.
Conclusion: We propose that a disruption of centrosome integrity and/or spindle organization may play an important role in the development of microcephaly in MCPH2.
Background: We report on a patient with genetically confirmed overlapping diagnoses of CMT1A and FSHD. This case adds to the increasing number of unique patients presenting with atypical phenotypes, particularly in FSHD. Even if a mutation in one disease gene has been found, further genetic testing might be warranted in cases with unusual clinical presentation.
Case presentation: The reported 53 years old male patient suffered from walking difficulties and foot deformities first noticed at age 20. Later on, he developed scapuloperoneal and truncal muscle weakness, along with atrophy of the intrinsic hand and foot muscles, pes cavus, claw toes and a distal symmetric hypoesthesia. Motor nerve conduction velocities were reduced to 20 m/s in the upper extremities, and not educible in the lower extremities, sensory nerve conduction velocities were not attainable. Electromyography showed both, myopathic and neurogenic changes. A muscle biopsy taken from the tibialis anterior muscle showed a mild myopathy with some neurogenic findings and hypertrophic type 1 fibers. Whole-body muscle MRI revealed severe changes in the lower leg muscles, tibialis anterior and gastrocnemius muscles were highly replaced by fatty tissue. Additionally, fatty degeneration of shoulder girdle and straight back muscles, and atrophy of dorsal upper leg muscles were seen. Taken together, the presenting features suggested both, a neuropathy and a myopathy. Patient's family history suggested an autosomal dominant inheritance. Molecular testing revealed both, a hereditary motor and sensory neuropathy type 1A (HMSN1A, also called Charcot-Marie-Tooth neuropathy 1A, CMT1A) due to a PMP22 gene duplication and facioscapulohumeral muscular dystrophy (FSHD) due to a partial deletion of the D4Z4 locus (19 kb).
Conclusion: Molecular testing in hereditary neuromuscular disorders has led to the identification of an increasing number of atypical phenotypes. Nevertheless, finding the right diagnosis is crucial for the patient in order to obtain adequate medical care and appropriate genetic counseling, especially in the background of arising curative therapies.
Distinct functional roles for the two SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia
(2014)
Defects in SLX4, a scaffold for DNA repair nucleases, cause Fanconi anemia due to defective repair of inter-strand DNA crosslinks (ICLs). Some FA patients have an SLX4 deletion removing two tandem UBZ4-type ubiquitin-binding domains, implicated in protein recruitment to sites of DNA damage. Here we show that human SLX4 is recruited to sites of ICL induction but the UBZ-deleted form of SLX4 in cells from FA patients is not. SLX4 recruitment does not require ubiquitination of FANCD2, or the E3 ligases RNF8, RAD18 and BRCA1. We show that the first (UBZ-1), but not the second UBZ domain of SLX4 binds to ubiquitin polymers with a preference for K63-linked chains. Furthermore, UBZ-1 is required for SLX4 recruitment to ICL sites, and for efficient ICL repair in murine fibroblasts. SLX4 UBZ-2 domain does not bind ubiquitin in vitro or contribute to ICL repair, but it is required for resolution of Holliday junctions in vivo. These data shed light on SLX4 recruitment, and suggest that there remain to be identified ubiquitinated ligands and E3 ligases critical for ICL repair.
Objective:
To determine the survival in a population of German patients with Duchenne muscular dystrophy.
Patients and methods:
Information about 94 patients born between 1970 and 1980 was obtained by telephone interviews and questionnaires. In addition to age of death or actual age during the investigation, data concerning clinical course and medical interventions were collected.
Results:
67 patients with molecularly confirmed diagnoses had a median survival of 24.0 years. Patients without molecular confirmation (clinical diagnosis only) had a chance of 67 % to reach that age. Grouping of our patient cohort according to the year of death (before and after 2000), ventilation was recognized as main intervention affecting survival with ventilated reaching a median survival of 27.0 years. For those without ventilation it was 19.0 years.
Conclusion and clinical relevance:
our study provides survival data for a cohort of DMD patients in Germany stratified by year of death. Median survival was 24.0 years in patients confirmed by molecular testing. Ventilated patients had a median survival of 27 years. We consider this piece of information helpful in the medical care of DMD patients.
Introduction
Miyoshi myopathy, a type of distal myopathy with predominant involvement of the posterior calf muscles, has been assigned to mutations in the dysferlin gene. However, many of the late-onset limb-girdle and distal myopathies that resemble dysferlinopathy or Miyoshi myopathy remain unclassified, even after extensive immunohistological and genetic analysis.
Case presentation
We report the case of a 59-year-old Caucasian man with distal myopathy and exercise-induced myalgia, preferentially of the leg muscles, closely resembling the Miyoshi phenotype. Magnetic resonance imaging of his calf muscles showed typical fatty replacement of the medial heads of the gastrocnemius muscles and soleus muscles, with progression to the adductor longus muscles over a time course of two years. However, genetic analysis revealed that the phenotype of our patient was not related to a mutation in the dysferlin gene but to a novel homozygous splice mutation in the anoctamin 5 gene. Mutations in the anoctamin 5 gene have so far been identified only in some cases of limb-girdle and distal myopathy. Mutations in the anoctamin 5 gene have been assigned to limb-girdle muscular dystrophy type 2L, while distal Miyoshi-like phenotypes have been classified as Miyoshi myopathy type 3.
Conclusion
The case presented in this report further strengthens the underlying genetic heterogeneity in Miyoshi myopathy-like phenotypes and adds another family to non-dysferlin, Miyoshi myopathy type 3 of late-onset. Furthermore, our case supports the recent observation that anoctamin 5 mutations are a primary cause of distal non-dysferlin myopathies. Therefore, given the increasing number of anoctamin 5 mutations in Miyoshi-like phenotypes, genetic analysis should include an anoctamin 5 screen in late-onset limb-girdle and distal myopathies.
Prenatal stress-induced programming of genome-wide promoter DNA methylation in 5-HTT-deficient mice
(2014)
The serotonin transporter gene (5-HTT/SLC6A4)-linked polymorphic region has been suggested to have a modulatory role in mediating effects of early-life stress exposure on psychopathology rendering carriers of the low-expression short (s)-variant more vulnerable to environmental adversity in later life. The underlying molecular mechanisms of this gene-by-environment interaction are not well understood, but epigenetic regulation including differential DNA methylation has been postulated to have a critical role. Recently, we used a maternal restraint stress paradigm of prenatal stress (PS) in 5-HTT-deficient mice and showed that the effects on behavior and gene expression were particularly marked in the hippocampus of female 5-Htt+/- offspring. Here, we examined to which extent these effects are mediated by differential methylation of DNA. For this purpose, we performed a genome-wide hippocampal DNA methylation screening using methylated-DNA immunoprecipitation (MeDIP) on Affymetrix GeneChip Mouse Promoter 1.0 R arrays. Using hippocampal DNA from the same mice as assessed before enabled us to correlate gene-specific DNA methylation, mRNA expression and behavior. We found that 5-Htt genotype, PS and their interaction differentially affected the DNA methylation signature of numerous genes, a subset of which showed overlap with the expression profiles of the corresponding transcripts. For example, a differentially methylated region in the gene encoding myelin basic protein (Mbp) was associated with its expression in a 5-Htt-, PS- and 5-Htt × PS-dependent manner. Subsequent fine-mapping of this Mbp locus linked the methylation status of two specific CpG sites to Mbp expression and anxiety-related behavior. In conclusion, hippocampal DNA methylation patterns and expression profiles of female prenatally stressed 5-Htt+/- mice suggest that distinct molecular mechanisms, some of which are promoter methylation-dependent, contribute to the behavioral effects of the 5-Htt genotype, PS exposure and their interaction.
The ERCC4 protein forms a structure-specific endonuclease involved in the DNA damage response. Different cancer syndromes such as a subtype of Xeroderma pigmentosum, XPF, and recently a subtype of Fanconi Anemia, FA-Q, have been attributed to biallelic ERCC4 gene mutations. To investigate whether monoallelic ERCC4 gene defects play some role in the inherited component of breast cancer susceptibility, we sequenced the whole ERCC4 coding region and flanking untranslated portions in a series of 101 Byelorussian and German breast cancer patients selected for familial disease (set 1, n = 63) or for the presence of the rs1800067 risk haplotype (set 2, n = 38). This study confirmed six known and one novel exonic variants, including four missense substitutions but no truncating mutation. Missense substitution p.R415Q (rs1800067), a previously postulated breast cancer susceptibility allele, was subsequently screened for in a total of 3,698 breast cancer cases and 2,868 controls from Germany, Belarus or Russia. The Gln415 allele appeared protective against breast cancer in the German series, with the strongest effect for ductal histology (OR 0.67; 95%CI 0.49; 0.92; p = 0.003), but this association was not confirmed in the other two series, with the combined analysis yielding an overall Mantel-Haenszel OR of 0.94 (95% CI 0.81; 1.08). There was no significant effect of p.R415Q on breast cancer survival in the German patient series. The other three detected ERCC4 missense mutations included two known rare variants as well as a novel substitution, p.E17V, that we identified on a p.R415Q haplotype background. The p.E17V mutation is predicted to be probably damaging but was present in just one heterozygous patient. We conclude that the contribution of ERCC4/FANCQ coding mutations to hereditary breast cancer in Central and Eastern Europe is likely to be small.
Single Nucleotide Polymorphisms (SNPs) in genes involved in the DNA Base Excision Repair (BER) pathway could be associated with cancer risk in carriers of mutations in the high-penetrance susceptibility genes BRCA1 and BRCA2, given the relation of synthetic lethality that exists between one of the components of the BER pathway, PARP1 (poly ADP ribose polymerase), and both BRCA1 and BRCA2. In the present study, we have performed a comprehensive analysis of 18 genes involved in BER using a tagging SNP approach in a large series of BRCA1 and BRCA2 mutation carriers. 144 SNPs were analyzed in a two stage study involving 23,463 carriers from the CIMBA consortium (the Consortium of Investigators of Modifiers of BRCA1 and BRCA2). Eleven SNPs showed evidence of association with breast and/or ovarian cancer at p<0.05 in the combined analysis. Four of the five genes for which strongest evidence of association was observed were DNA glycosylases. The strongest evidence was for rs1466785 in the NEIL2 (endonuclease VIII-like 2) gene (HR: 1.09, 95% CI (1.03-1.16), p = 2.7x10(-3)) for association with breast cancer risk in BRCA2 mutation carriers, and rs2304277 in the OGG1 (8-guanine DNA glycosylase) gene, with ovarian cancer risk in BRCA1 mutation carriers (HR: 1.12 95% CI: 1.03-1.21, p = 4.8x10(-3)). DNA glycosylases involved in the first steps of the BER pathway may be associated with cancer risk in BRCA1/2 mutation carriers and should be more comprehensively studied.
Background: A growing number of non-coding regulatory mutations are being identified in congenital disease. Very recently also some exons of protein coding genes have been identified to act as tissue specific enhancer elements and were therefore termed exonic enhancers or "eExons".
Methods: We screened a cohort of 134 unrelated families with split-hand/split-foot malformation (SHFM) with high resolution array CGH for CNVs with regulatory potential.
Results: In three families with an autosomal dominant non-syndromic SHFM phenotype we detected microdeletions encompassing the exonic enhancer (eExons) 15 and 17 of DYNC1I1. In a fourth family, who had hearing loss in addition to SHFM, we found a larger deletion of 510 kb including the eExons of DYNC1I1 and, in addition, the human brain enhancer hs1642. Exons 15 and 17 of DYNC1I1 are known to act as tissue specific limb enhancers of DLX5/6, two genes that have been shown to be associated with SHFM in mice. In our cohort of 134 unrelated families with SHFM, deletions of the eExons of DYNC1I1 account for approximately 3% of the cases, while 17p13.3 duplications were identified in 13% of the families, 10q24 duplications in 12%, and TP63 mutations were detected in 4%.
Conclusions: We reduce the minimal critical region for SHFM1 to 78 kb. Hearing loss, however, appears to be associated with deletions of a more telomeric region encompassing the brain enhancer element hs1642. Thus, SHFM1 as well as hearing loss at the same locus are caused by deletion of regulatory elements. Deletions of the exons with regulatory potential of DYNC1I1 are an example of the emerging role of exonic enhancer elements and their implications in congenital malformation syndromes.
Background: Myofibrillar myopathies (MFM) are a group of phenotypically and genetically heterogeneous neuromuscular disorders, which are characterized by protein aggregations in muscle fibres and can be associated with multisystemic involvement.
Methods: We screened a large cohort of 38 index patients with MFM for mutations in the nine thus far known causative genes using Sanger and next generation sequencing (NGS). We studied the clinical and histopathological characteristics in 38 index patients and five additional relatives (n = 43) and particularly focused on the associated multisystemic symptoms.
Results: We identified 14 heterozygous mutations (diagnostic yield of 37%), among them the novel p. Pro209Gln mutation in the BAG3 gene, which was associated with onset in adulthood, a mild phenotype and an axonal sensorimotor polyneuropathy, in the absence of giant axons at the nerve biopsy. We revealed several novel clinical phenotypes and unusual multisystemic presentations with previously described mutations: hearing impairment with a FLNC mutation, dysphonia with a mutation in DES and the first patient with a FLNC mutation presenting respiratory insufficiency as the initial symptom. Moreover, we described for the first time respiratory insufficiency occurring in a patient with the p. Gly154Ser mutation in CRYAB. Interestingly, we detected a polyneuropathy in 28% of the MFM patients, including a BAG3 and a MYOT case, and hearing impairment in 13%, including one patient with a FLNC mutation and two with mutations in the DES gene. In four index patients with a mutation in one of the MFM genes, typical histological findings were only identified at the ultrastructural level (29%).
Conclusions: We conclude that extraskeletal symptoms frequently occur in MFM, particularly cardiac and respiratory involvement, polyneuropathy and/or deafness. BAG3 mutations should be considered even in cases with a mild phenotype or an adult onset. We identified a genetic defect in one of the known genes in less than half of the MFM patients, indicating that more causative genes are still to be found. Next generation sequencing techniques should be helpful in achieving this aim.